Endoribonuclease compositions and methods of use thereof
The present disclosure provides variant Csy4 endoribonucleases, nucleic acids encoding the variant Csy4 endoribonucleases, and host cells genetically modified with the nucleic acids. The variant Csy4 endoribonucleases find use in a variety of applications, which are also provided. The present disclosure also provides methods of detecting a specific sequence in a target polyribonucleotide; and methods of regulating production of a target RNA in a eukaryotic cell.
1. An in vitro method of regulating production of a target RNA from a precursor RNA in a eukaryotic cell, the method comprising:
introducing into said eukaryotic cell a recombinant expression vector comprising a nucleotide sequence encoding an enzymatically active sequence-specific Csy4 endoribonuclease, wherein the Csy4 endoribonuclease comprises an amino acid sequence having at least 95% amino acid sequence identity to the amino acid sequence set forth in SEQ ID NO:8, wherein the target RNA comprises a GUUCACUGCCGUAUAGGCAG (SEQ ID NO:103) cleavage site in the 3′ untranslated region of a precursor RNA comprising the target RNA, and wherein said Csy4 endoribonuclease is produced in the cell and cleaves said target RNA from the precursor RNA at the cleavage site, thereby regulating production of the target RNA.
2. The method of claim 1 , wherein the target RNA species is a regulatory RNA.
3. The method of claim 1 , wherein cleavage of said target RNA from a precursor RNA inactivates the precursor RNA.
4. The method of claim 1 , wherein said nucleotide sequence encoding an enzymatically active sequence-specific Csy4 endoribonuclease is operably linked to a promoter.
5. The method of claim 4 , wherein said method comprises contacting the promoter with an agent that activates said promoter.
6. The method of claim 4 , wherein said cleaving of said target RNA from said precursor RNA inactivates said target RNA.
7. The method of claim 4 , wherein said cleaving of said target RNA from said precursor RNA reduces expression levels of said target RNA.
8. The method of claim 4 , wherein said precursor RNA comprises a poly-A tail.
9. The method of claim 4 , wherein the Csy4 endoribonuclease comprises an amino acid sequence having at least 98% amino acid sequence identity to the amino acid sequence set forth in SEQ ID NO: 8.
10. The method of claim 4 , wherein the Csy4 endoribonuclease comprises a moiety that provides a detectable signal.
11. The method of claim 10 , wherein the moiety is a fluorophore, a quantum dot, an enzyme other than the endoribonuclease, or a nanoparticle.
12. The method of claim 4 , wherein the Csy4 endoribonuclease binds an RNA substrate comprising the nucleotide sequence 5′-GUUCACUGCCGUAUAGGCAGCUAAGAAA-3′ (SEQ ID NO: 1).
13. The method of claim 4 , wherein said eukaryotic cell is a primary cell.
14. The method of claim 4 , wherein said eukaryotic cell is a mammalian cell.